| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 134,482 | 186,185 | 141,221 | 290,064 | | Cost of Revenue | 143,043 | 145,123 | 122,032 | 186,223 | | | Gross Profit | (8,561) | 41,062 | 19,189 | 103,841 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,889 | 29,359 | 21,828 | 43,686 | | Non Recurring |
-
|
-
| 81,843 | 336,752 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (33,450) | 11,703 | (84,482) | (276,597) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26,394 | 39,041 | 46,237 | (9,343) | | Earnings Before Interest And Taxes | (7,056) | 50,744 | (38,245) | (285,940) | | Interest Expense | 27,237 | 22,258 | 21,428 | 18,138 | | Income Before Tax | (34,293) | 28,486 | (59,673) | (304,078) | | Income Tax Expense | (9,999) | 6,380 | (12,995) | 15,115 | | Minority Interest | 2,744 | 4,477 |
-
| (310) | | | | Net Income From Continuing Ops | (21,550) | 26,583 | (46,678) | (319,503) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (262) | (3,785) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,550) | 26,583 | (46,940) | (323,288) | | Preferred Stock And Other Adjustments |
-
| (2,502) | 2,502 |
-
| | | Net Income Applicable To Common Shares | ($21,550) | $24,081 | ($44,438) | ($323,288) |
|
0.03% Nasdaq 
0.38 (1.56%) 
Income Statement
